Dr. Brendan Jones is a registered US patent attorney in Foley Hoag’s Intellectual Property group. He practices intellectual property law with a focus on the life science industry by representing clients in patent prosecution and litigation matters and post-grant proceedings.
Dr. Jones manages the worldwide prosecution of extensive patent portfolios for a diverse array of clients, including large and small biotechnology companies and academic institutions. Over the course of his more than 10 years with Foley Hoag, he has successfully obtained U.S. and foreign patents for his clients covering a wide range of technologies, including protein, antibody, siRNA and small molecule therapeutics, drug discovery platforms, genetically modified organisms, molecular diagnostic platforms, and downstream pharmaceutical processing systems. Dr. Jones prides himself on working closely with his clients to help them implement an optimized intellectual property strategy closely aligned with their institution’s strategic goals.More »